Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: a pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab.
Cancer
; 120(12): 1780-6, 2014 Jun 15.
Article
em En
| MEDLINE
| ID: mdl-24633933
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Neoplasias Pancreáticas
/
Albumina Sérica
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Biomarcadores Tumorais
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Cancer
Ano de publicação:
2014
Tipo de documento:
Article